Status:

COMPLETED

Better Together Study

Lead Sponsor:

Emory University

Collaborating Sponsors:

National Institute on Minority Health and Health Disparities (NIMHD)

Conditions:

Type 2 Diabetes

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

This study (Aim 1) seeks to test that a culturally-tailored lifestyle intervention is feasible and acceptable for immigrant men from South Asia and West Africa. This will be a pre-post pilot study of ...

Detailed Description

South Asians and Africans are growing immigrant groups at high risk for diabetes in the US. South Asian (SA) (ancestry originating from India, Pakistan, Bangladesh and other parts of South Asia) and S...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for Aim 1:
  • Men \>18 years of age
  • Diagnosis of Type 2 Diabetes (T2D) (documented A1c of ≥ 5.7% or fasting blood glucose of \>100) or prediabetes
  • A family member or peer is willing to participate and attend all sessions as a social partner (if enrolling in dyad arm)
  • Proficiency in English(if in dyad, at least one member of each dyad)
  • Willingness to provide written consent
  • Inclusion Criteria for Aim 2:
  • Proficient in English
  • Age greater than or equal to 18 years
  • Exclusion Criteria Aim 1 and 2:
  • Type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced)
  • Malignancy or life-threatening illness with life expectancy of \<5 years
  • End-stage disease or serious illness that prohibits participation (e.g. end-stage renal disease or class IV congestive heart failure)
  • Inability to perform unsupervised physical activity
  • Diagnosed with cognitive deficits or limited decision-making capacity
  • Alcohol or substance abuse
  • Homelessness or no fixed address.

Exclusion

    Key Trial Info

    Start Date :

    April 4 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2024

    Estimated Enrollment :

    108 Patients enrolled

    Trial Details

    Trial ID

    NCT05275231

    Start Date

    April 4 2022

    End Date

    January 1 2024

    Last Update

    March 3 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Emory Family Medicine Center

    Dunwoody, Georgia, United States, 30338